Ateria Health – A clinical stage biotechnology company focused on developing products to improve gut health and carbohydrate metabolism

Russam led an Executive Search to find the CEO for Ateria Health; a position that required a strong leader comfortable in the scientific and commercial worlds.  

Our search was extensive and thorough, and the selection process led by Douglas Dundonald, a key investor from Scientific Venture Partners, involved the whole team in the UK and Australia. Neil Wickers was successfully in position by October 2021. 

Douglas Dundonald says:  We are delighted that Neil Wickers has joined the team and excited for the success of Ateria Health under his leadership, as he will be able to draw on his varied background and experience, to tackle a demanding role, as the company moves both to a public listing and launches its first product in 2022. Russam’s tenacity and wider search throughout this project gave us the result we were looking for.

Neil Wickers says:  When Cathy Kay approached me, she immediately captured my interest I am passionate about the sector and delighted and excited to build this business. Cathy’s support throughout the selection process is much appreciated too.

You can contact Cathy for more information on cathy.kay@russam.co.uk